Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $422,123 | $353,223 | $342,941 | $975,541 |
| - Cash | $8,980 | $23,714 | $28,285 | $29,299 |
| + Debt | $212,314 | $207,762 | $245,802 | $220,094 |
| Enterprise Value | $625,457 | $537,271 | $560,458 | $1,166,336 |
| Revenue | $33,120 | $7,035 | $55,640 | $11,357 |
| % Growth | 370.8% | -87.4% | 389.9% | – |
| Gross Profit | $13,541 | -$7,550 | $36,987 | -$1,553 |
| % Margin | 40.9% | -107.3% | 66.5% | -13.7% |
| EBITDA | -$18,707 | -$34,064 | $7,404 | -$21,710 |
| % Margin | -56.5% | -484.2% | 13.3% | -191.2% |
| Net Income | -$123,033 | -$50,469 | -$28,373 | -$31,247 |
| % Margin | -371.5% | -717.4% | -51% | -275.1% |
| EPS Diluted | -1.78 | -0.88 | -0.52 | -0.69 |
| % Growth | -102.3% | -69.2% | 24.6% | – |
| Operating Cash Flow | -$11,143 | $8,959 | -$28,662 | -$38,019 |
| Capital Expenditures | $302 | -$5,598 | -$13,365 | -$12,293 |
| Free Cash Flow | -$10,841 | $3,361 | -$42,027 | -$50,312 |